The University of Chicago Header Logo

Connection

Richard A. Larson to Immunotoxins

Back to Details
This is a "connection" page, showing publications Richard A. Larson has written about Immunotoxins.
Richard A. Larson
Connection Strength
0.564
Immunotoxins
  1. Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin). Leukemia. 2002 Sep; 16(9):1627-36.
    View in: PubMed
    Score: 0.212
  2. Current use and future development of gemtuzumab ozogamicin. Semin Hematol. 2001 Jul; 38(3 Suppl 6):24-31.
    View in: PubMed
    Score: 0.196
  3. Gemtuzumab ozogamicin: time to resurrect? J Clin Oncol. 2012 Nov 10; 30(32):3921-3.
    View in: PubMed
    Score: 0.107
  4. Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse. J Clin Oncol. 2001 Jul 01; 19(13):3244-54.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.